MetLife Investment Management’s Franklin Templeton BEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.31M | Sell |
69,508
-1,643
| -2% | -$49.2K | 0.01% | 1067 |
|
|
2026
Q1 | $1.68M | Sell |
71,151
-2,469
| -3% | -$63.5K | 0.01% | 1146 |
|
|
2025
Q4 | $1.76M | Sell |
73,620
-2,397
| -3% | -$55K | 0.01% | 1146 |
|
|
2025
Q3 | $1.76M | Sell |
76,017
-2,940
| -4% | -$72.7K | 0.01% | 1150 |
|
|
2025
Q2 | $1.88M | Sell |
78,957
-1,543
| -2% | -$31.8K | 0.01% | 1025 |
|
|
2025
Q1 | $1.55M | Sell |
80,500
-851
| -1% | -$17.1K | 0.01% | 1159 |
|
|
2024
Q4 | $1.65M | Buy |
81,351
+1,533
| +2% | +$32.3K | 0.01% | 1149 |
|
|
2024
Q3 | $1.61M | Buy |
79,818
+105
| +0.1% | +$2.26K | 0.01% | 1139 |
|
|
2024
Q2 | $1.78M | Buy |
79,713
+9,455
| +13% | +$228K | 0.01% | 1028 |
|
|
2024
Q1 | $1.97M | Buy |
70,258
+1,775
| +3% | +$48.9K | 0.01% | 957 |
|
|
2023
Q4 | $2.04M | Sell |
68,483
-1,865
| -3% | -$46.4K | 0.01% | 939 |
|
|
2023
Q3 | $1.73M | Sell |
70,348
-2,091
| -3% | -$56.6K | 0.01% | 972 |
|
|
2023
Q2 | $1.93M | Sell |
72,439
-1,161
| -2% | -$30K | 0.01% | 941 |
|
|
2023
Q1 | $1.98M | Sell |
73,600
-608
| -0.8% | -$17.8K | 0.01% | 914 |
|
|
2022
Q4 | $1.96M | Sell |
74,208
-1,214
| -2% | -$30.1K | 0.01% | 910 |
|
|
2022
Q3 | $1.62M | Sell |
75,422
-106
| -0.1% | -$2.72K | 0.01% | 971 |
|
|
2022
Q2 | $1.76M | Sell |
75,528
-1,137
| -1% | -$29.1K | 0.01% | 946 |
|
|
2022
Q1 | $2.14M | Buy |
76,665
+14,580
| +23% | +$445K | 0.01% | 964 |
|
|
2021
Q4 | $2.08M | Sell |
62,085
-1,515
| -2% | -$49.9K | 0.02% | 858 |
|
|
2021
Q3 | $1.89M | Buy |
63,600
+461
| +0.7% | +$14.4K | 0.02% | 881 |
|
|
2021
Q2 | $2.02M | Sell |
63,139
-1,896
| -3% | -$61.4K | 0.02% | 871 |
|
|
2021
Q1 | $1.93M | Sell |
65,035
-1,137
| -2% | -$31.1K | 0.02% | 883 |
|
|
2020
Q4 | $1.65M | Sell |
66,172
-1,648
| -2% | -$36.8K | 0.02% | 916 |
|
|
2020
Q3 | $1.38M | Sell |
67,820
-4,722
| -7% | -$99.2K | 0.02% | 890 |
|
|
2020
Q2 | $1.52M | Buy |
72,542
+647
| +0.9% | +$12.2K | 0.02% | 843 |
|
|
2020
Q1 | $1.2M | Sell |
71,895
-2,199
| -3% | -$50.5K | 0.02% | 825 |
|
|
2019
Q4 | $1.92M | Sell |
74,094
-2,663
| -3% | -$72.4K | 0.02% | 831 |
|
|
2019
Q3 | $2.22M | Sell |
76,757
-4,386
| -5% | -$134K | 0.02% | 739 |
|
|
2019
Q2 | $2.82M | Sell |
81,143
-170,887
| -68% | -$5.81M | 0.03% | 651 |
|
|
2019
Q1 | $8.35M | Buy |
252,030
+166,920
| +196% | +$5.27M | 0.03% | 644 |
|
|
2018
Q4 | $2.52M | Sell |
85,110
-3,821
| -4% | -$117K | 0.03% | 646 |
|
|
2018
Q3 | $2.7M | Sell |
88,931
-4,893
| -5% | -$158K | 0.03% | 720 |
|
|
2018
Q2 | $3.01M | Sell |
93,824
-4,133
| -4% | -$138K | 0.04% | 606 |
|
|
2018
Q1 | $3.4M | Sell |
97,957
-3,159
| -3% | -$128K | 0.04% | 531 |
|
|
2017
Q4 | $4.38M | Buy |
+101,116
| New | +$4.38M | 0.05% | 406 |
|
Other funds holding BEN
PCOC
ACL
MetLife Investment Management's BEN Position: Q2 2026 in Review
MetLife Investment Management reduced its Franklin Templeton (BEN) stake by 2.3% in Q2 2026, selling an estimated $49.2K and leaving 69,508 shares worth $2.31M. The position accounts for 0.01% of the portfolio, ranked #1067.
MetLife Investment Management first reported a position in BEN in Q4 2017 and has held it in 35 quarters since. The position peaked at $8.35M in Q1 2019. 664 funds tracked by Wall St. Rank hold BEN as of Q2 2026.
- MetLife Investment Management held 69,508 shares of Franklin Templeton worth $2.31M as of Q2 2026.
- MetLife Investment Management sold 1,643 Franklin Templeton shares in Q2 2026, an estimated $49.2K.
- Franklin Templeton made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1067 holding.
- MetLife Investment Management first reported a position in Franklin Templeton in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Franklin Templeton position peaked at $8.35M in Q1 2019.
- 664 funds tracked by Wall St. Rank held Franklin Templeton as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.